George L. Sing - Feb 26, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Feb 26, 2024
Transactions value $
-$579,170
Form type
4
Date filed
2/28/2024, 04:04 PM
Previous filing
Feb 26, 2024
Next filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $207K +500 +1.9% $413.33 26.8K Feb 26, 2024 Direct
transaction REGN Common Stock Sale -$495K -500 -1.86% $990.00 26.3K Feb 26, 2024 Direct
transaction REGN Common Stock Options Exercise $207K +500 +1.9% $413.33 26.8K Feb 26, 2024 Direct
transaction REGN Common Stock Sale -$498K -500 -1.86% $995.00 26.3K Feb 26, 2024 Direct
holding REGN Common Stock 750 Feb 26, 2024 by Spouse
holding REGN Common Stock 400 Feb 26, 2024 by Spouse/Cust Son
holding REGN Common Stock 1K Feb 26, 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -15.78% $0.00 5.34K Feb 26, 2024 Common Stock 1K $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.